6-(6-(1-methyl-1H-pyrazol-4-yl)imidazo(1,2-b)pyridazin-3-ylmethyl)quinoline,
NVP BVU972,
NVP-BVU972,
NVP-BVU972,
1185763-69-2,
CHEMBL1738731,
C20H16N6,
6-((6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl)methyl)quinoline,
6-{[6-(1-Methyl-1h-Pyrazol-4-Yl)imidazo[1,2-B]pyridazin-3-Yl]methyl}quinoline,
3qti,
RNCNPRCUHHDYPC-UHFFFAOYSA-N,
NVPBVU972,
NVP BVU972,
MLS006010964,
NVP-BVU 972,
NVP-BVU-972,
BVU972,
SCHEMBL1659100,
AOB2279,
BVU-972,
DTXSID40657890,
HMS3656L04,
BCP03600,
EX-A2116,
2607AH,
BDBM50146169,
s2761,
ZINC66166253,
AKOS026750599,
BCP9000466,
CS-0967,
NCGC00346689-01,
NCGC00346689-06,
AK474020,
BC600327,
HY-15456,
SC-94554,
SMR004702768,
BCP0726000188,
SW219959-1,
W-5940,
958025-66-6 , C20H16N6 , NVP BVU972,
6-[[6-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline,
6-[6-(1-methyl-1h-pyrazol-4-yl)-imidazo[1,2-b]pyridazin-3-ylmethyl]-quinoline,
Mubritinib (TAK 165),
cc-601,
A8489,
A11150,
6-[[6-(1-Methyl-1H-pyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]methyl]quinoline,